Libo Zhao1, Xiurong Li1, Zhiguo Zhang1, Chunqing Song1, Caihong Guo1, Yinghua Zhang2, Ying Zhang1, Li Li1, Guilong Lu1, Guowen Zheng1, Kesong Wang3, Wenzhong Pei4, Lei Han5. 1. Department of Oncology, Daxing Hospital Affiliated to Capital Medical University, Beijing, China. 2. Department of Interventional Radiology, Beijing You'an Hospital, Capital Medical University Beijing, China. 3. Department of Oncology, Beijing Shunyi Hospital, Beijing, China. 4. Department of Oncology, The Luhe Teaching Hospital of the Capital Medical University, Beijing, China. 5. Department of Oncology, Daxing Hospital Affiliated to Capital Medical University, Beijing, China. Electronic address: drhanlei@163.com.
Abstract
OBJECTIVE: To determine the prevalence, correlates and recognition rates of depressive disorders (DDs) in Chinese inpatients with cancer. METHODS: Four hundred and sixty cancer inpatients were recruited from the oncology ward of a university hospital in Beijing, China. Patients were interviewed with a Chinese version of the Mini International Neuropsychiatric Interview 5.0 by eight trained psychiatrists. Case records of inpatients with DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) DDs were reviewed to determine whether treating oncologists made a diagnosis of depression, prescribed antidepressant medications and/or recommended psychiatric consultation/referral. RESULTS: The 1-month prevalence rates (95% confidence intervals) of DDs and major depressive disorder (MDD) were 25.9% (21.9%-29.9%) and 12.6% (9.6%-15.6%), respectively. In our multiple logistic regression analysis, being unmarried [odds ratio (OR)=1.41], cancer stage of metastasis (OR=2.35), time since cancer diagnosis ≤20 months (OR=2.05), frequent pain (OR=1.99~6.83) and being scored between two and four on the Eastern Cooperative Oncology Group Scale (OR=2.25~4.97) were independently associated with depression. Only 6.9% of patients with MDD were recognized by treating oncologists. CONCLUSIONS: DDs are very common among Chinese inpatients with cancer. The high prevalence rate and low recognition rate of depression in cancer patients indicate a pressing need for routine screening, evaluation and treatment of depression in this patient population.
OBJECTIVE: To determine the prevalence, correlates and recognition rates of depressive disorders (DDs) in Chinese inpatients with cancer. METHODS: Four hundred and sixty cancer inpatients were recruited from the oncology ward of a university hospital in Beijing, China. Patients were interviewed with a Chinese version of the Mini International Neuropsychiatric Interview 5.0 by eight trained psychiatrists. Case records of inpatients with DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) DDs were reviewed to determine whether treating oncologists made a diagnosis of depression, prescribed antidepressant medications and/or recommended psychiatric consultation/referral. RESULTS: The 1-month prevalence rates (95% confidence intervals) of DDs and major depressive disorder (MDD) were 25.9% (21.9%-29.9%) and 12.6% (9.6%-15.6%), respectively. In our multiple logistic regression analysis, being unmarried [odds ratio (OR)=1.41], cancer stage of metastasis (OR=2.35), time since cancer diagnosis ≤20 months (OR=2.05), frequent pain (OR=1.99~6.83) and being scored between two and four on the Eastern Cooperative Oncology Group Scale (OR=2.25~4.97) were independently associated with depression. Only 6.9% of patients with MDD were recognized by treating oncologists. CONCLUSIONS: DDs are very common among Chinese inpatients with cancer. The high prevalence rate and low recognition rate of depression in cancerpatients indicate a pressing need for routine screening, evaluation and treatment of depression in this patient population.
Authors: Saira Sanjida; Kelly Mulvogue; Joanne Shaw; Jeremy Couper; David Kissane; Sallie-Anne Pearson; Melanie A Price; Monika Janda Journal: Support Care Cancer Date: 2017-09-19 Impact factor: 3.603